Thoracic Research and Practice
Original Article

Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Point Prevalence Study

1.

Department of Intensive Care, University of Medical Sciences Şehit Prof. Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkey

2.

Department of Intensive Care, Health Sciences University Süreyyapaşa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, İstanbul, Turkey

3.

Department of Intensive Care, Health Sciences University Dr. Suat Seren Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, İstanbul, Turkey

4.

Department of Intensive Care, Health Sciences University Sultan Abdülhamid Han Training and Research Hospital, İstanbul, Turkey

5.

Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey

6.

Department of Intensive Care, TC Ministry of Health, Mersin City Hospital, Mersin, Turkey

7.

Department of Intensive Care, Tarsus Medikalpark Hospital, Mersin, Turkey

8.

Department of Intensive Care, Health Sciences University Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey

9.

Department of Intensive Care, Erciyes University Faculty of Medicine, Kayseri, Turkey

10.

Department of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey

11.

Department of Intensive Care, Health Sciences University Ankara Atatürk Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Ankara, Turkey

12.

Department of Intensive Care, Pamukkale University Faculty of Medicine, Denizli, Turkey

Thorac Res Pract 2019; 1: -
DOI: 10.5152/ThoracResPract.2024.23117
Read: 677 Downloads: 669 Published: 09 March 2024

OBJECTIVE: Coronavirus disease 2019 (COVID-19) caused morbidity and mortality worldwide. Besides the acute effects, subacute and long-term effects are defined as long-COVID causing morbidity. The intensive care unit (ICU) data of long-COVID-19 cases were evaluated with the participation of 11 centers.

MATERIAL AND METHODS: Study was designed by Turkish Thoracic Society Respiratory Failure and Intensive Care Working Group to evaluate long COVID-19 patients. All patients followed up in the ICU with long-COVID diagnosis were included in point prevelance study.

RESULTS: A total of 41 long COVID-19 patients from 11 centers were included in the study. Half of the patients were male, mean age was 66 ± 14, body mass index was 27 ± 5. Hypertension, diabetes mellitus, lung cancer, malignancy, and heart failure rates were 27%, 51%, 34%, 34%, and 27%, respectively. Eighty percent had received COVID vaccine. Patients had moderate hypoxemic respiratory failure. APACHE II, SOFA score was 18 (14-26), 6 (3-8), respectively. Forty-six percent received invasive mechanical ventilator support, 42% were sepsis, 17% were septic shock. Bilateral (67%), interstitial involvement (37%) were most common in chest x-ray. Fibrosis (27%) was detected in thorax tomography. Seventy-one percent of patients received antibiotherapy (42% carbapenem, 22% linezolid). Sixty-one percent of the patients received corticosteroid treatment.

CONCLUSION: More than half of the patients had pneumonia and the majority of them used broad-spectrum antibiotics. Presence of comorbidities and malignancies, intensive care severity scores, intubation, and sepsis rates were high. Receiving corticosteroid treatment and extensive bilateral radiologic involvement due to COVID-19 might be the reasons for the high re-admission rate for the ICUs.

Cite this article as: Tunçay E, Moçin Ö, Ediboğlu Ö, et al. Evaluation of long-Coronavirus Disease 2019 cases readmitted to intensive care units due to acute respiratory failure: Point prevalence study. Thorac Res Pract. 2024. [epub ahead of print]

Files
EISSN 2979-9139